TFA Therapeutics RAJAF Growth Metrics (2021-2025)

OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

TFA Therapeutics Quarterly Growth Metrics

Periods 5 quarters
Latest Dec 2025

TFA Therapeutics reported asset growth of 0.73% for the quarter ended Dec 2025. These growth metrics cover 5 quarters of results from Dec 2021 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Dec2021 Dec2022 Dec2023 Dec2024 Dec2025
Growth Ratios
Assets Growth (1y) 15.48%-35.49%59.24%37.95%0.73%
Assets Growth (3y) 5.86%12.32%30.31%
Assets Growth (5y) 10.51%
Assets (QoQ) 86.45%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 33,739.12%-93.34%248.58%61.37%-91.42%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) 328.33%-27.90%-21.56%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y) 61.19%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) 36.62%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) 84,010.10%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) -568.90%
EBIT Growth (1y) 426.41%
EBT Growth (1y) 326.15%
EPS (Basic) Growth (1y) 1,199.10%
EPS (Basic) Growth (3y) 296.17%
EPS (Diluted) Growth (1y) 1,199.10%
EPS (Diluted) Growth (3y) 296.17%
Free Cash Flow Growth (1y)FCF Growth (1y) -1,232.02%
Net Cash Flow Growth (1y)NCF Growth (1y) 105.22%
Net Income Growth (1y) 463.64%
Net Income Growth (3y) 131.90%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) 1,269.65%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y) 309.90%
Operating Income Growth (1y)Op. Inc Growth (1y) 426.41%
Profit After Tax Growth (1y)PAT Growth (1y) 326.15%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) 0.10%-95.59%3,627.67%38.90%-7.08%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y) 18.02%31.64%263.71%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y) 16.24%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) 82.16%
Total Debt Growth (1y) 1.48%-68.84%536.95%42.99%3.08%
Total Debt Growth (3y) 26.29%41.58%110.96%
Total Debt Growth (5y) 24.31%
Total Debt (QoQ) 633.50%

TFA Therapeutics Growth Metrics API

Pull TFA Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RAJAF&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY